ENDOGENOUS PROSTACYCLIN CONTRIBUTES TO THE EFFICACY OF A THROMBOXANE SYNTHETASE INHIBITOR FOR PREVENTING CORONARY-ARTERY THROMBOSIS

This publication has 9 references indexed in Scilit:

• Intravenous infusion of prostacyclin sodium in man: clinical effects and influence on platelet adenosine diphosphate sensitivity and adenosine 3':5'-cyclic monophosphate levels.
  Circulation, 1981
• THE BENEFICIAL-EFFECTS OF ORAL IBUPROFEN ON CORONARY-ARTERY THROMBOSIS AND MYOCARDIAL ISCHEMIA IN THE CONSCIOUS DOG
  1980
• ROLE OF PLATELET-PROSTAGLANDIN SYNTHESIS IN SHEAR-INDUCED PLATELET ALTERATIONS
  1980
• Characterization of prostacyclin synthesis in cultured human arterial smooth muscle cells, venous endothelial cells and skin fibroblasts
  Cell, 1979
• Rat aortic strip as a bioassay tissue for thromboxane A2 and rabbit aorta contracting substance (RCS) released from guinea pig lung by bradykinin or anaphylaxis
  Prostaglandins, 1979
• Platelet and Blood Vessel Arachidonate Metabolism and Interactions
  Journal of Clinical Investigation, 1979
• Modulation of human platelet adenylate cyclase by prostacyclin (PGX)
  Prostaglandins, 1977
• A lipid peroxide inhibits the enzyme in blood vessel microsomes that generates from prostaglandin endoperoxides the substance (prostaglandin X) which prevents platelet aggregation
  Prostaglandins, 1976
• Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides
  Prostaglandins, 1976